Observational studyEndocrinology, diabetes & metabolism2026
Frequency of Insulin Resistance in Overweight Patients With Metabolic-Associated Fatty Liver Disease (MAFLD) at a Tertiary Healthcare Centre in Bangladesh.
Observational study in Endocrinology, diabetes & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn Bangladesh, the prevalence of MAFLD patients is about 33.86%. Most of the patients with MAFLD are also strongly associated with hepatic and adipose tissue insulin resistance (IR). Homeostasis model assessment of insulin resistance (HOMA-IR) is a simple and useful method for evaluating insulin resistance and β cell function.
methodsThis observational cross-sectional study was carried out in the outpatient department of Hepatology, Bangladesh Medical University. The subjects were non-alcoholic overweight patients with sonographic evidence of fatty liver disease aged 18 years or above. Participants were subjected to a pre-designed questionnaire including personal data. Assessment of medical history, physical examinations and investigations to measure IR were performed. Statistical analyses were carried out by using the SPSS version PC 26.0.
resultsThe Majority of the participants, precisely 60% (95% confidence interval [CI]: 45.2, 73.6) had insulin resistance (IR) and median HOMA-IR index was 2.85. Patients with acanthosis nigricans had significantly higher IR biochemically (Mean HOMA-IR index; 5.79 vs. 2.89), which was significant statistically. No significant correlation was observed between HOMA-IR and alternative metabolic markers, including METS-IR, TG/HDL-c ratio and BMI.
conclusionA high frequency (60%) of insulin resistance was found among overweight, non-diabetic patients with MAFLD. This finding underscores the immense value of regular screening for hyperglycemia in this population. With the increasing burden of metabolic syndrome, early identification of IR would enable timely preventive interventions-potentially slowing the progression to type 2 diabetes and consequently reducing subsequent risk of developing diabetes-related complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.